FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA OKs Expanded Indication for Reblozyl

FDA approves a Bristol Myers Squibb BLA supplement for Reblozyl (luspatercept-aamt) for treating anemia in patients with very low- to intermediate-ris...

latest-news-card-1
Human Drugs

FDA Monitoring Social Media Drug Promotion: Post

Two SheppardMullin attorneys say the second Warning Letter issued this year by the CDER Office of Prescription Drug Promotion shows the agency is clos...

latest-news-card-1
Human Drugs

9 GA Congress Members Want Chemo Transparency

A bipartisan group of nine members of Congress from Georgia calls for greater FDA transparency on efforts to resolve the current shortage of chemother...

latest-news-card-1
Human Drugs

FDA Promotes Dose Optimization Innovation: Report

FDA researchers say the agency is working collaboratively to find innovative approaches to optimizing dosages of cancer drugs.

latest-news-card-1
Human Drugs

Texas Approves Drug Import Plan

Texas approves a bill to create a program to import drugs from Canada pending HHS approval.

latest-news-card-1
Human Drugs

Lawmakers Ask FDA to Fix Orange Book Loopholes

Senator Elizabeth Warren (D-MA) and Rep. Pramila Jayapal (D-WA) urge FDA commissioner Robert Califf to restrict patents that are listed in the Orange ...

latest-news-card-1
Medical Devices

ICU Medical Infusion Pump Cleared

FDA clears an ICU Medical 510(k) for the Plum Duo infusion pump with LifeShield infusion safety software.

latest-news-card-1
Federal Register

Info Collection on FDA Surveys

Federal Register notice: FDA sends to OMB an information collection extension entitled Customer/Partner Service Satisfaction Surveys.

latest-news-card-1
Human Drugs

FDA OKs 15 Vyvanse Generics

FDA approves 15 ANDAs representing the first generics of Takedas Vyvanse (lisdexamfetamine dimesylate) capsules and chewable tablets, indicated for at...

latest-news-card-1
Human Drugs

Janssen Files sBLA for Expanded Rybrevant

Janssen Pharmaceutical files a supplemental BLA seeking an expanded approval for Rybrevant (amivantamab-vmjw) combination use with chemotherapy (carb...